case_images: PMC10812848_01
case_images: Preoperative aspect of the patient with dermatochalasis at upper eyelids and fat and skin excess at lower lids.
case_images: ICRP_A_2306984_F0001_C.jpg
case_images: PMC10812848_01_ICRP_A_2306984_F0001_C.jpg
case_images: F0001
case_images: Intraoperative view of the fat compartments' prominence of the left lower eyelid before conservative excision; corneal protectors were used during surgery.
case_images: ICRP_A_2306984_F0002_C.jpg
case_images: PMC10812848_01_ICRP_A_2306984_F0002_C.jpg
case_images: F0002
case_images: Orbital medial fat pad was isolated (Figure 2) and removed conservatively with the use of bipolar forceps.
case_images: PMC10812848_02
case_images: PMC10812848_03
case_images: Bilateral conjunctival chemosis present at three weeks post operative follow-up.
case_images: ICRP_A_2306984_F0003_C.jpg
case_images: PMC10812848_03_ICRP_A_2306984_F0003_C.jpg
case_images: F0003
case_images: PMC10812848_04
case_images: Chemosis was still present two months after upper and lower lid blepharoplasty.
case_images: ICRP_A_2306984_F0004_C.jpg
case_images: PMC10812848_04_ICRP_A_2306984_F0004_C.jpg
case_images: F0004
case_images: Two months after surgery, after failure of conservative therapy, persistence of the pathology was observed (Figure 4).
case_images: Intraoperative aspect of methylene blue demarcation of the chemotic area at right eye before snip conjunctivoplasty.
case_images: ICRP_A_2306984_F0005_C.jpg
case_images: PMC10812848_04_ICRP_A_2306984_F0005_C.jpg
case_images: F0005
case_images: At surgery, under local anesthetic, after delimitation of the chemotic conjunctiva with Methylene blue, a minimally invasive conjunctivoplasty (snip conjunctivoplasty) was performed by the ophtalmologist together with our plastic surgery team (Figure 5).
case_images: Six months follow-up showing stable resolution of the complication.
case_images: ICRP_A_2306984_F0006_C.jpg
case_images: PMC10812848_04_ICRP_A_2306984_F0006_C.jpg
case_images: F0006
case_images: No recurrence was observed at six months follow-up (Figure 6).